TargetMol

Palmatine

Product Code:
 
TAR-T5S0802
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T5S0802-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S0802-250mg250mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S0802-1g1g£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
1. Palmatine is an inhibitor of dopamine generation. 2. Palmatine could potentially be developed for the treatment of flavivirus infections. 3. Palmatine has been used in the treatment of jaundice, dysentery, hypertension, inflammation, and liver-related diseases.
CAS:
3486-67-7
Formula:
C21H22NO4
Molecular Weight:
352.409
Pathway:
Neuroscience; Metabolism
Purity:
0.9711
SMILES:
COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4cc3-c2cc1OC
Target:
Indoleamine 2,3-Dioxygenase (IDO); AChR; AChE

References

Lin X, Chen D, Chu X, et al.Oxypalmatin regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids.Phytomedicine.2023: 154752. Hambright H G, Batth I S, Xie J, et al. Palmatine inhibits growth and invasion in prostate cancer cell: Potential role forrpS6/NF?B/FLIP[J]. Mol Carcinog, 2015, 54(10):1227-1234. Song Y, Xu C, Li X, et al. Palmatine Alleviates LPS-Induced Acute Lung Injury Via Interfering the Interaction of TAK1 and TAB1. Biochemical Pharmacology. 2022 Aug;202:115120.